A newly approved ‘living drug’ could save more cancer patients’ lives
Amtagvi, approved for advanced melanoma, is the first T cell therapy for solid tumors
The human immune system produces T cells (one shown in a colorized scanning electron microscope image) that can attack cancer cells.
NIAID